Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS (STAR)
This study has been completed.
Sponsor:
Avanir Pharmaceuticals
Collaborator:
INC Research
Information provided by:
Avanir Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00573443
First received: December 13, 2007
Last updated: June 24, 2011
Last verified: June 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | September 2009 |
| Primary Completion Date: | June 2009 (Final data collection date for primary outcome measure) |